Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

KalVista Pharmaceuticals (KALV) Gross Profit: 2013-2025

Historic Gross Profit for KalVista Pharmaceuticals (KALV) over the last 10 years, with Apr 2025 value amounting to -$5.8 million.

  • KalVista Pharmaceuticals' Gross Profit rose 30.69% to $3.8 million in Q2 2020 from the same period last year, while for Apr 2020 it was $12.7 million, marking a year-over-year decrease of 21.31%. This contributed to the annual value of -$5.8 million for FY2025, which is 111.57% down from last year.
  • Per KalVista Pharmaceuticals' latest filing, its Gross Profit stood at -$5.8 million for FY2025, which was down 111.57% from $50.0 million recorded in FY2024.
  • In the past 5 years, KalVista Pharmaceuticals' Gross Profit registered a high of $50.0 million during FY2024, and its lowest value of -$5.8 million during FY2025.
  • For the 2-year period, KalVista Pharmaceuticals' Gross Profit averaged around $22.1 million, with its median value being $22.1 million (2024).
  • Data for KalVista Pharmaceuticals' Gross Profit shows a maximum YoY crashed of 111.57% (in 2025) over the last 5 years.
  • KalVista Pharmaceuticals' Gross Profit (Yearly) stood at $50.0 million in 2024, then plummeted by 111.57% to -$5.8 million in 2025.